Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by Toll-like receptor agonists

International Immunopharmacology

Volumn 15, Issue 1, 2013, Pages 38-41

  Shin, Hwa Jeong ^a   Shon, Dong Hwa ^b   Youn, Hyung Sun ^a  

^a Soonchunhyang University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Inducible nitric oxide synthase; Inflammation; Isobavachalcone; Nuclear factor B; Toll like receptors

Indexed keywords

ANTIINFLAMMATORY AGENT; CHALCONE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOBAVACHALCONE; LIPOPOLYSACCHARIDE; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANGELICA; ANGELICA KEISKEI; ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CYTOTOXICITY; ENZYME INHIBITION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHALCONES; ENZYME INHIBITORS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE SYNTHASE TYPE II; POLY I-C; TOLL-LIKE RECEPTORS;

EID: 84872292708     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.11.005     Document Type: Article

References (26)

1. K. Takeda, and S. Akira Toll-like receptors in innate immunity Int Immunol 17 2005 1 14
2. S. Moncada Nitric oxide: discovery and impact on clinical medicine J R Soc Med 92 1999 164 169
3. M.E. Turini, and R.N. DuBois Cyclooxygenase-2: a therapeutic target Annu Rev Med 53 2002 35 57
4. Y.J. Surh Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review Food Chem Toxicol 40 2002 1091 1097
5. R. Nishimura, K. Tabata, M. Arakawa, Y. Ito, Y. Kimura, and T. Akihisa Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma Biol Pharm Bull 30 2007 1878 1883
6. M. Matsuura, Y. Kimura, K. Nakata, K. Baba, and H. Okuda Artery relaxation by chalcones isolated from the roots of Angelica keiskei Planta Med 67 2001 230 235
7. T. Akihisa, H. Tokuda, M. Ukiya, M. Iizuka, S. Schneider, and K. Ogasawara Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects Cancer Lett 201 2003 133 137
8. Y. Kimura, M. Taniguchi, and K. Baba Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots Planta Med 70 2004 211 219
9. Y. Kimura, and K. Baba Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol Int J Cancer 106 2003 429 437
10. M. Sugii, M. Ohkita, M. Taniguchi, K. Baba, Y. Kawai, and C. Tahara Xanthoangelol D isolated from the roots of Angelica keiskei inhibits endothelin-1 production through the suppression of nuclear factor-kappaB Biol Pharm Bull 28 2005 607 610
11. T. Akihisa, H. Tokuda, D. Hasegawa, M. Ukiya, Y. Kimura, and F. Enjo Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects J Nat Prod 69 2006 38 42
12. V. Kuete, and L.P. Sandjo Isobavachalcone: an overview Chin J Integr Med 18 2012 543 547
13. Y.H. Ling, L. Liebes, Y. Zou, and R. Perez-Soler Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells J Biol Chem 278 2003 33714 33723
14. H. Jing, X. Zhou, X. Dong, J. Cao, H. Zhu, and J. Lou Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells Cancer Lett 294 2010 167 177
15. H. Matsuda, S. Kiyohara, S. Sugimoto, S. Ando, S. Nakamura, and M. Yoshikawa Bioactive constituents from Chinese natural medicines. XXXIII. Inhibitors from the seeds of Psoralea corylifolia on production of nitric oxide in lipopolysaccharide-activated macrophages Biol Pharm Bull 32 2009 147 149
16. S.L. Foster, and R. Medzhitov Gene-specific control of the TLR-induced inflammatory response Clin Immunol 130 2009 7 15
17. H.S. Youn, J.Y. Lee, K.A. Fitzgerald, H.A. Young, S. Akira, and D.H. Hwang Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex J Immunol 175 2005 3339 3346
18. S.J. Park, S.M. Yun, A.N. Lee, S.I. Ahn, M.Y. Lee, and H.S. Youn Costunolide inhibits cyclooxygenase-2 expression induced by Toll-like receptor 3 or 4 agonist Toxicol Environ Health Sci 1 2010 122 126
19. S.J. Park, and H.S. Youn Isoliquiritigenin suppresses the Toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of Toll-like receptors by targeting TBK1 J Agric Food Chem 58 2010 4701 4705
20. A. Murakami, and H. Ohigashi Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals Int J Cancer 121 2007 2357 2363
21. A. Murakami, D. Takahashi, K. Koshimizu, and H. Ohigashi Synergistic suppression of superoxide and nitric oxide generation from inflammatory cells by combined food factors Mutat Res 523-524 2003 151 161
22. P. Vallance Nitric oxide: therapeutic opportunities Fundam Clin Pharmacol 17 2003 1 10
23. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, and K.K. Park Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutat Res 480-481 2001 243 268
24. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
25. K.A. Fitzgerald, S.M. McWhirter, K.L. Faia, D.C. Rowe, E. Latz, and D.T. Golenbock IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway Nat Immunol 4 2003 491 496
26. E. Meylan, K. Burns, K. Hofmann, V. Blancheteau, F. Martinon, and M. Kelliher RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation Nat Immunol 5 2004 503 507